Q4 2018 13F Holders as of 31 Dec 2018
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
26,828,643
-
Number of holders
-
11
-
Total 13F shares, excl. options
-
1,151,824
-
Shares change
-
+1,151,824
-
Total reported value, excl. options
-
$7,048,000
-
Value change
-
+$7,048,000
-
Number of buys
-
11
-
Price
-
$6.12
Significant Holders of Eton Pharmaceuticals, Inc. - Common Stock (ETON) as of Q4 2018
11 filings reported holding ETON - Eton Pharmaceuticals, Inc. - Common Stock as of Q4 2018.
Eton Pharmaceuticals, Inc. - Common Stock (ETON) has 11 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1,151,824 shares
of 26,828,643 outstanding shares and own 4.3% of the company stock.
Largest 10 shareholders include Opaleye Management Inc. (523,000 shares), AWM Investment Company, Inc. (425,000 shares), Apollo Management Holdings, L.P. (90,000 shares), Diametric Capital, LP (59,002 shares), PRELUDE CAPITAL MANAGEMENT, LLC (25,270 shares), BOOTHBAY FUND MANAGEMENT, LLC (11,966 shares), BlackRock Inc. (9,909 shares), WELLS FARGO & COMPANY/MN (6,000 shares), BANK OF AMERICA CORP /DE/ (1,118 shares), and MORGAN STANLEY (400 shares).
This table shows the top 11 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.